Dragonfly Biosciences has with immediate effect terminated its 4th December 2018 joint venture agreement with Borganic Inc/Stillcanna Inc. and the supply agreement thereunder. The termination includes a claim for Stillcanna's share of the JV plant and a multimillion pound claim for damages.